Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
CONCLUSION: The higher prevalence of Covid-19 in ASD patients along with the significant correlations with important clinical features and therapeutic regimens suggests the need to develop targeted prevention/management strategies during the current pandemic wave.PMID:34477509 | DOI:10.2174/1381612827666210903103935
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Clodoveo Ferri Dilia Giuggioli Vincenzo Raimondo Massimo L'Andolina Lorenzo Dagna Antonio Tavoni Francesco Caso Francesco Ursini Ruscitti Piero Maurizio Caminiti Rosario Foti Valeria Riccieri Serena Guiducci Roberta Pellegrini Elisabetta Zanatta Giuseppe Source Type: research
More News: Arthritis | Aspirin | Autoimmune Disease | COVID-19 | Drugs & Pharmacology | Italy Health | Pandemics | Rheumatology | SARS | Scleroderma | Statistics